Theme:

Drug Design 2020
DRUG DESIGN 2020

Drug Design 2020

Drug Design Conferences Committee is glad to announce “22nd International Conference on Drug Design and Development” in Amsterdam, Netherlands during October 26-27, 2020.

Drug Design 2020 conference will be a valuable and important platform for inspiring international and interdisciplinary exchange at the forefront of drug research. Over the course of 2 days, internationally-renowned speakers will describe how their research journeys have developed in response to contemporary challenges: Inspirational and innovative lessons in drug research. The attending experts and industry partners will also provide a fantastic networking experience.

The series of keynote talks, poster presentations, workshops, discussions and networking events will keep participants engaged in learning and making new connections at Drug Design 2020.

Drug Design conferences will bring together scientists, researchers, entrepreneurs, academicians, medical officers, CEO’s, CSO’s and technologists from all over the world to debate on the latest scientific advances in the field of drug discovery & development that help to shape current and future challenges in drug research. We hope that you will take this opportunity to join us for academic exchange and visit the city of Amsterdam, Netherlands.

Benefits of Attending Drug Design 2020

This year Drug Design 2020 gives you single best chance to achieve the biggest gathering of members. Exchange ideas and create network with leading Health care professionals and researchers from more than 40 countries. It’s a two-day event (i.e. October 26-27, 2020). This full day event is a platform where you can also meet our previous year eminent speakers and can hear about their experiences, including practical tips and tricks. It is also a great opportunity to network with other new experts in this field.

For Researchers and Faculty members:

  • Keynote Presentations
  • Speaker Presentations
  • Poster Presentation
  • Symposium Hosting
  • Workshop Organizing
  • Special Sessions Presentation

For Universities, Associations & Societies:

  • Association Partnering
  • Collaboration Proposals
  • Academic Partnering
  • Group Participation

For students and Research Scholars:

  • Poster Competition
  • Young Researcher Forum
  • Student Attendee
  • Group Registrations

For Business Delegates:

  • Speaker Presentations
  • Symposium Hosting
  • Book Launch Event
  • Networking Opportunities
  • Audience Participation

For product manufacturers:

  • Exhibitor and Vendor Booths
  • Sponsorship Opportunities
  • Product Launch
  • Workshop Organization
  • Scientific Partnering
  • Marketing and Networking with Clients

Bioavailability and Bioequivalence

Targeted Based Pharmaceutical Formulation

Drug Delivery Techniques

Medicinal Chemistry in Drug Discovery

Drug Discovery and Development 

CADD Computer Aided Drug Delivery

Vaccine Drug Delivery Systems

Novel Drug Delivery Systems

Medical Devices for Drug Delivery

Proteomics and Bioinformatics in Drug Delivery

Business Opportunities in Drug Delivery

Drug Metabolism and Toxicology

Pharmacokinetics and Pharmacodynamics

Nanotechnology and Nanomedicine

Bio-pharmaceutics

The factors propelling for the growth of the market of drug discovery include the rising prevalence of a wide range of diseases (such as CNS-related disorders and cardiovascular), rising upcoming patent expiration of blockbuster drugs and healthcare expenditure.

The diverse range of diseases, kidney related complications, infectious diseases diabetes, and primarily cardiovascular disease, has a high prevalence, global wide. Thus, the ascending prevalence of a wide range of diseases among all age groups and its burden, globally wide, drives the demands for drug discovery and its market.

There has been an upsurge in the usage of advanced technologies, such as high throughput, combinational chemistry and bioinformatics for better drug candidate identification. Drug discovery has evolved significantly with various emerging technologies, helping the process to become more accurate, refined, and less time consuming. Due to automation, multi-detector readers, software, high-throughput screening and imaging hardware is one of the most widely used drug discovery technologies.

In recent years, there has been a rising demand for speciality medicines that are expected to ultimately influence the small molecule drug discovery market in a positive manner, as most of the speciality medicines are small molecules.

The new pharmaceutical technology advancement rise gradually in the healthcare expenditure regionally. There is a need for redirecting the resources, with high expenditure so the transition helps better usability of healthcare expenditure for drug development is under progress.

Biologics Drug is the Segment that is Expected to Grow Fastest Under Drug Type:

A biologic drug is a product which is produced from living organisms or contains subunits of living organisms. Biologic drugs include a wide range of products derived from human, animal, or microorganisms. Biologic drugs are used for the treatment of numerous conditions and diseases and are the most advanced therapies available. Biologic treatments are for autoimmune diseases, which include the treatments for rheumatoid arthritis, Crohn's disease psoriasis, ulcerative colitis, and a range of related disorders, and have continued to see increasing usage across the world. The biopharmaceutics are expected to be fueled by innovations in oncology, diabetes and autoimmune treatments, with particular important opportunities for biologics in the autoimmune and oncology sectors.

The ascending applications of biopharmaceutics for the treatment of chronic diseases are leading to the increased demand for these drugs in the market. Moreover, due to the aforementioned factors, biologic drugs dominate the biologics in the current healthcare market.

Asia-Pacific is Expected to Increase with the Fastest Growth Over the Forecast Period:

The Asia-Pacific is the fastest-growing region, due to the presence of skilled labour at an reasonable cost, favourable government policies and the rise in disposable income that are contributing to the market growth. There has also been phenomenal growth in the outsourcing companies in the Chinese region, over the last decade, which has complemented the restructuring of the R&D that has taken place. Thus, owing to the large deals of pharmaceutical companies and more number of research being done, the market for drug discovery is expected to grow.

Major Players:

 

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 26-27, 2020
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View

Media Partners